Alterity Therapeutics (ATHE) Assets (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Assets of $37.4 million for Q4 2025, up 441.83% year-over-year from $6.9 million in Q4 2024, and up 26.78% quarter-over-quarter from $29.5 million in Q2 2025.
Alterity Therapeutics (ATHE) Assets (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $37.4 million for Q4 2025.
- In Q4 2025, Assets rose 441.83% year-over-year to $37.4 million; the TTM figure through Dec 2025 stood at $37.4 million (up 441.83% YoY), while the FY2025 annual figure was $29.5 million, up 132.67% from the prior year.
- Assets for Q4 2025 stood at $37.4 million, up from $29.5 million in the prior quarter.
- The five-year high for Assets was $37.4 million in Q4 2025, with the low at $273176.4 in Q2 2023.
- The 5-year median for Assets is $23.9 million (2022), against an average of $21.1 million.
- The sharpest annual moves came in 2023 and 2024: Assets slumped 99.08% in 2023, then surged 4537.63% in 2024.
- Alterity Therapeutics' Assets stood at $32.7 million in 2021, then slumped by 32.99% to $21.9 million in 2022, then plunged by 34.13% to $14.4 million in 2023, then sank by 52.26% to $6.9 million in 2024, then jumped by 441.83% to $37.4 million in 2025.
- Business Quant data shows ATHE's Assets at $37.4 million in Q4 2025, $29.5 million in Q2 2025, and $6.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | 37.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.37 Mn |
| Jun 30, 2025 | 29.48 Mn |
| Dec 31, 2024 | 6.90 Mn |
| Jun 30, 2024 | 12.67 Mn |
| Dec 31, 2023 | 14.45 Mn |
| Jun 30, 2023 | 273,176.36 |
| Dec 31, 2022 | 21.93 Mn |
| Jun 30, 2022 | 29.63 Mn |
| Dec 31, 2021 | 32.73 Mn |
| Jun 30, 2021 | 25.86 Mn |
| Dec 31, 2020 | 27.34 Mn |
| Jun 30, 2020 | 6.49 Mn |
| Dec 31, 2019 | 9.90 Mn |
| Jun 30, 2019 | 13.95 Mn |
| Dec 31, 2018 | 10.15 Bn |
| Jun 30, 2018 | 14.18 Mn |
| Dec 31, 2017 | 16.87 Mn |
| Jun 30, 2017 | 18.99 Bn |
| Dec 31, 2016 | 22.81 Mn |
| Jun 30, 2016 | 25.18 Bn |